MENUicon menu

Corporate Partnerships

Innovative research and therapeutic applications require collaborative efforts to become reality. Lentigen and its parent company Miltenyi Biotec have a long and successful history in implementing new technologies for clinical research and cell and gene therapy applications.

If you are interested in

  • innovative approaches to cellular engineering with lentiviral vectors

  • optimizing transduction and transgene expression

  • bringing immunotherapy and gene therapy approaches into clinical reality


please contact us to discuss opportunities for scientific collaboration including and beyond lentiviral vector development and manufacturing.